Your browser doesn't support javascript.
loading
Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates.
Udompholkul, Parima; Baggio, Carlo; Gambini, Luca; Sun, Yu; Zhao, Ming; Hoffman, Robert M; Pellecchia, Maurizio.
Afiliação
  • Udompholkul P; Division of Biomedical Sciences, School of Medicine, University of California Riverside, 900 University Avenue, Riverside, CA 92521, USA.
  • Baggio C; Division of Biomedical Sciences, School of Medicine, University of California Riverside, 900 University Avenue, Riverside, CA 92521, USA.
  • Gambini L; Division of Biomedical Sciences, School of Medicine, University of California Riverside, 900 University Avenue, Riverside, CA 92521, USA.
  • Sun Y; AntiCancer Inc., 7917 Ostrow St., San Diego, CA 92111, USA.
  • Zhao M; Department of Surgery, University of California, 9300 Campus Point Dr #7220, La Jolla, San Diego, CA 92037, USA.
  • Hoffman RM; AntiCancer Inc., 7917 Ostrow St., San Diego, CA 92111, USA.
  • Pellecchia M; AntiCancer Inc., 7917 Ostrow St., San Diego, CA 92111, USA.
Molecules ; 26(12)2021 Jun 17.
Article em En | MEDLINE | ID: mdl-34204178
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor EphA2 Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor EphA2 Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article